Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Minnicozzi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Immunological Reviews|June 21, 2011
Innate immunity in allergic diseaseMichael Minnicozzi, Richard T Sawyer, Matthew J Fenton
Current Allergy and Asthma Reports|July 12, 2018
Is Allergen Immunotherapy in Children Disease Modifying? A Review of the EvidenceAmanda K Rudman Spergel, Michael Minnicozzi, Lisa M Wheatley, et al.
Respiratory Research|March 1, 2006
Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitroBrian N Chorley, Anne L Crews, Yuehua Li, et al.
Journal of Pharmacological and Toxicological Methods|March 2, 2006
An enzyme-linked immunosorbent assay (ELISA) for the determination of mucin levels in bronchoalveolar lavage fluidJonathan E Phillips, Natalie R Case, Chander Celly, et al.
The Journal of Allergy and Clinical Immunology|March 6, 2012
Asthma outcomes: symptomsJerry A Krishnan, Robert F Lemanske, Glorisa J Canino, et al.
The Journal of Allergy and Clinical Immunology|February 15, 2020
On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat AllergyThomas A E Platts-Mills, Scott P Commins, Tilo Biedermann, et al.
The Journal of Allergy and Clinical Immunology|March 6, 2012
Asthma outcomes: biomarkersStanley J Szefler, Sally Wenzel, Robert Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 2007
A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammationRichard W Chapman, Michael Minnicozzi, Chander S Celly, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2007
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonistsJianhua Chao, Arthur G Taveras, Jianping Chao, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2012
Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD)Bruce S Bochner, Wendy Book, William W Busse, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Immunological Reviews|June 21, 2011
Innate immunity in allergic diseaseMichael Minnicozzi, Richard T Sawyer, Matthew J Fenton
Current Allergy and Asthma Reports|July 12, 2018
Is Allergen Immunotherapy in Children Disease Modifying? A Review of the EvidenceAmanda K Rudman Spergel, Michael Minnicozzi, Lisa M Wheatley, et al.
Respiratory Research|March 1, 2006
Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitroBrian N Chorley, Anne L Crews, Yuehua Li, et al.
Journal of Pharmacological and Toxicological Methods|March 2, 2006
An enzyme-linked immunosorbent assay (ELISA) for the determination of mucin levels in bronchoalveolar lavage fluidJonathan E Phillips, Natalie R Case, Chander Celly, et al.
The Journal of Allergy and Clinical Immunology|March 6, 2012
Asthma outcomes: symptomsJerry A Krishnan, Robert F Lemanske, Glorisa J Canino, et al.
The Journal of Allergy and Clinical Immunology|February 15, 2020
On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat AllergyThomas A E Platts-Mills, Scott P Commins, Tilo Biedermann, et al.
The Journal of Allergy and Clinical Immunology|March 6, 2012
Asthma outcomes: biomarkersStanley J Szefler, Sally Wenzel, Robert Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 2007
A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammationRichard W Chapman, Michael Minnicozzi, Chander S Celly, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2007
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonistsJianhua Chao, Arthur G Taveras, Jianping Chao, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2012
Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD)Bruce S Bochner, Wendy Book, William W Busse, et al.
Pageof 2